Protein and Peptide Therapeutics Market, Global Outlook and Forecast 2023-2029

Report ID: MMG61202 | Category: Pharma & Healthcare | Pages: 65 | Format: PDF | Published Date: February 28,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
This report aims to provide a comprehensive presentation of the global market for Protein and Peptide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein and Peptide Therapeutics. This report contains market size and forecasts of Protein and Peptide Therapeutics in global, including the following market information:
Global Protein and Peptide Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Protein and Peptide Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Protein and Peptide Therapeutics include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Protein and Peptide Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Protein and Peptide Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Protein and Peptide Therapeutics Market Segment Percentages, by Type, 2022 (%)
    Injection
    Oral
Global Protein and Peptide Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Protein and Peptide Therapeutics Market Segment Percentages, by Application, 2022 (%)
    Cancer
    Metabolic Disorders
    Central Nervous System
    Other
Global Protein and Peptide Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Protein and Peptide Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Protein and Peptide Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Protein and Peptide Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sanofi
    Teva
    Novo Nordisk
    Takeda
    Eli Lilly
    AstraZeneca
    Novartis
    AbbVie
    Ipsen
    Ferring
    Merck
    The Medicines
    J & J
Outline of Major Chapters:
Chapter 1: Introduces the definition of Protein and Peptide Therapeutics, market overview.
Chapter 2: Global Protein and Peptide Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Protein and Peptide Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein and Peptide Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Protein and Peptide Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Protein and Peptide Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Protein and Peptide Therapeutics Overall Market Size
    2.1 Global Protein and Peptide Therapeutics Market Size: 2022 VS 2029
    2.2 Global Protein and Peptide Therapeutics Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Protein and Peptide Therapeutics Players in Global Market
    3.2 Top Global Protein and Peptide Therapeutics Companies Ranked by Revenue
    3.3 Global Protein and Peptide Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Protein and Peptide Therapeutics Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Protein and Peptide Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Protein and Peptide Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Protein and Peptide Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Protein and Peptide Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Protein and Peptide Therapeutics Market Size Markets, 2022 & 2029
        4.1.2 Injection
        4.1.3 Oral
    4.2 By Type - Global Protein and Peptide Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Protein and Peptide Therapeutics Revenue, 2018-2023
        4.2.2 By Type - Global Protein and Peptide Therapeutics Revenue, 2024-2029
        4.2.3 By Type - Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Protein and Peptide Therapeutics Market Size, 2022 & 2029
        5.1.2 Cancer
        5.1.3 Metabolic Disorders
        5.1.4 Central Nervous System
        5.1.5 Other
    5.2 By Application - Global Protein and Peptide Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Protein and Peptide Therapeutics Revenue, 2018-2023
        5.2.2 By Application - Global Protein and Peptide Therapeutics Revenue, 2024-2029
        5.2.3 By Application - Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Protein and Peptide Therapeutics Market Size, 2022 & 2029
    6.2 By Region - Global Protein and Peptide Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Protein and Peptide Therapeutics Revenue, 2018-2023
        6.2.2 By Region - Global Protein and Peptide Therapeutics Revenue, 2024-2029
        6.2.3 By Region - Global Protein and Peptide Therapeutics Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Protein and Peptide Therapeutics Revenue, 2018-2029
        6.3.2 US Protein and Peptide Therapeutics Market Size, 2018-2029
        6.3.3 Canada Protein and Peptide Therapeutics Market Size, 2018-2029
        6.3.4 Mexico Protein and Peptide Therapeutics Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Protein and Peptide Therapeutics Revenue, 2018-2029
        6.4.2 Germany Protein and Peptide Therapeutics Market Size, 2018-2029
        6.4.3 France Protein and Peptide Therapeutics Market Size, 2018-2029
        6.4.4 U.K. Protein and Peptide Therapeutics Market Size, 2018-2029
        6.4.5 Italy Protein and Peptide Therapeutics Market Size, 2018-2029
        6.4.6 Russia Protein and Peptide Therapeutics Market Size, 2018-2029
        6.4.7 Nordic Countries Protein and Peptide Therapeutics Market Size, 2018-2029
        6.4.8 Benelux Protein and Peptide Therapeutics Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Protein and Peptide Therapeutics Revenue, 2018-2029
        6.5.2 China Protein and Peptide Therapeutics Market Size, 2018-2029
        6.5.3 Japan Protein and Peptide Therapeutics Market Size, 2018-2029
        6.5.4 South Korea Protein and Peptide Therapeutics Market Size, 2018-2029
        6.5.5 Southeast Asia Protein and Peptide Therapeutics Market Size, 2018-2029
        6.5.6 India Protein and Peptide Therapeutics Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Protein and Peptide Therapeutics Revenue, 2018-2029
        6.6.2 Brazil Protein and Peptide Therapeutics Market Size, 2018-2029
        6.6.3 Argentina Protein and Peptide Therapeutics Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Protein and Peptide Therapeutics Revenue, 2018-2029
        6.7.2 Turkey Protein and Peptide Therapeutics Market Size, 2018-2029
        6.7.3 Israel Protein and Peptide Therapeutics Market Size, 2018-2029
        6.7.4 Saudi Arabia Protein and Peptide Therapeutics Market Size, 2018-2029
        6.7.5 UAE Protein and Peptide Therapeutics Market Size, 2018-2029
7 Protein and Peptide Therapeutics Companies Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Protein and Peptide Therapeutics Major Product Offerings
        7.1.4 Sanofi Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.1.5 Sanofi Key News & Latest Developments
    7.2 Teva
        7.2.1 Teva Company Summary
        7.2.2 Teva Business Overview
        7.2.3 Teva Protein and Peptide Therapeutics Major Product Offerings
        7.2.4 Teva Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.2.5 Teva Key News & Latest Developments
    7.3 Novo Nordisk
        7.3.1 Novo Nordisk Company Summary
        7.3.2 Novo Nordisk Business Overview
        7.3.3 Novo Nordisk Protein and Peptide Therapeutics Major Product Offerings
        7.3.4 Novo Nordisk Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.3.5 Novo Nordisk Key News & Latest Developments
    7.4 Takeda
        7.4.1 Takeda Company Summary
        7.4.2 Takeda Business Overview
        7.4.3 Takeda Protein and Peptide Therapeutics Major Product Offerings
        7.4.4 Takeda Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.4.5 Takeda Key News & Latest Developments
    7.5 Eli Lilly
        7.5.1 Eli Lilly Company Summary
        7.5.2 Eli Lilly Business Overview
        7.5.3 Eli Lilly Protein and Peptide Therapeutics Major Product Offerings
        7.5.4 Eli Lilly Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.5.5 Eli Lilly Key News & Latest Developments
    7.6 AstraZeneca
        7.6.1 AstraZeneca Company Summary
        7.6.2 AstraZeneca Business Overview
        7.6.3 AstraZeneca Protein and Peptide Therapeutics Major Product Offerings
        7.6.4 AstraZeneca Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.6.5 AstraZeneca Key News & Latest Developments
    7.7 Novartis
        7.7.1 Novartis Company Summary
        7.7.2 Novartis Business Overview
        7.7.3 Novartis Protein and Peptide Therapeutics Major Product Offerings
        7.7.4 Novartis Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.7.5 Novartis Key News & Latest Developments
    7.8 AbbVie
        7.8.1 AbbVie Company Summary
        7.8.2 AbbVie Business Overview
        7.8.3 AbbVie Protein and Peptide Therapeutics Major Product Offerings
        7.8.4 AbbVie Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.8.5 AbbVie Key News & Latest Developments
    7.9 Ipsen
        7.9.1 Ipsen Company Summary
        7.9.2 Ipsen Business Overview
        7.9.3 Ipsen Protein and Peptide Therapeutics Major Product Offerings
        7.9.4 Ipsen Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.9.5 Ipsen Key News & Latest Developments
    7.10 Ferring
        7.10.1 Ferring Company Summary
        7.10.2 Ferring Business Overview
        7.10.3 Ferring Protein and Peptide Therapeutics Major Product Offerings
        7.10.4 Ferring Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.10.5 Ferring Key News & Latest Developments
    7.11 Merck
        7.11.1 Merck Company Summary
        7.11.2 Merck Business Overview
        7.11.3 Merck Protein and Peptide Therapeutics Major Product Offerings
        7.11.4 Merck Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.11.5 Merck Key News & Latest Developments
    7.12 The Medicines
        7.12.1 The Medicines Company Summary
        7.12.2 The Medicines Business Overview
        7.12.3 The Medicines Protein and Peptide Therapeutics Major Product Offerings
        7.12.4 The Medicines Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.12.5 The Medicines Key News & Latest Developments
    7.13 J & J
        7.13.1 J & J Company Summary
        7.13.2 J & J Business Overview
        7.13.3 J & J Protein and Peptide Therapeutics Major Product Offerings
        7.13.4 J & J Protein and Peptide Therapeutics Revenue in Global Market (2018-2023)
        7.13.5 J & J Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Protein and Peptide Therapeutics Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?